Becton Dickinson (LTS:0R19) FFO


LTS:0R19 Becton Dickinson & Co LTS:0R19
76 GF Score
Price $145.59
GF Value $190.16
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Becton Dickinson FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0R19
76GF Score
Becton Dickinson & Co LTS:0R19
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Becton Dickinson (LTS:0R19) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of $145.59 is trading 23.4% below its estimated GF Value™ of $190.16. GuruFocus considers Becton Dickinson to be Modestly Undervalued.

Key valuation signals for LTS:0R19:

  • FFO:
  • GF Value™: $190.16 vs. price of $145.59 (23.4% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the LTS:0R19 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
76GF Score

Get the complete analysis for LTS:0R19

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$145.59
Price
$190.16
GF Value